VOValéria de Oliveira

Valéria de Oliveira

*This is an algorithmically generated author record based on publicly available information.

Valéria de Oliveira has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Microbial β-glycosylation of entacapone by Cunninghamella echinulata ATCC 9245

    by Keyla R.M.D. Lustosa, Ricardo Menegatti, Rodolpho C. Braga, Luciano M. Lião, Valéria de Oliveira


  • Determination of the cardioactive prototype LASSBio-294 and its metabolites in dog plasma by LC–MS/MS: Application for a pharmacokinetic study

    by Rodolpho C. Braga, Andréa C.B. Tôrres, Camille B. Persiano, Rosângela O. Alves, Carlos A.M. Fraga, Eliezer J. Barreiro, Valéria de Oliveira


  • Open Access

    Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism

    by Carolina Horta Andrade, Lenis Medeiros de Freitas, Valéria de Oliveira

    From the identification of HIV as the agent causing AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research over the past twenty-six years have been formidable. Currently, there are twenty-five anti-HIV compounds which have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), cell entry inhibitors or fusion inhibitors (FIs), co-receptor inhibitors (CRIs), and integrase inhibitors (INIs). Metabolism by the host organism is one of the most important determinants of the pharmacokinetic profile of a drug. Formation of active or toxic metabolites will also have an impact on the pharmacological and toxicological outcomes. Therefore, it is widely recognized that metabolism studies of a new chemical entity need to be addressed early in the drug discovery process. This paper describes an overview of the metabolism of currently available anti-HIV drugs.


  • Open Access

    Selection of filamentous fungi of the Beauveria genus able to metabolize quercetin like mammalian cells

    by Eula Maria De M. B. Costa, Fabiana Cristina Pimenta, Wolf Christian Luz, Valéria De Oliveira

    Microbial biotransformations constitute an important alternative as models for drug metabolism study in mammalians and have been used for the industrial synthesis of chemicals with pharmaceutical purposes. Several microorganisms with unique biotransformation ability have been found by intensive screening and put in commercial applications. Ten isolates of Beauveria sp genus filamentous fungi, isolated from soil in the central Brazil, and Beauveria bassiana ATCC 7159 were evaluated for their capability of quercetin biotransformation. Biotransformation processes were carried out for 24 up to 96 hours and monitored by mass spectrometry analyses of the culture broth. All strains were able to metabolize quercetin, forming mammalian metabolites. The results were different from those presented by other microorganisms previously utilized, attrackting attention because of the great diversity of reactions. Methylated, sulphated, monoglucuronidated, and glucuronidated conjugated metabolites were simultaneously detected.


  • Open Access

    Selection of filamentous fungi of the Beauveria genus able to metabolize quercetin like mammalian cells

    by Eula Maria de M. B. Costa, Fabiana Cristina Pimenta, Wolf Christian Luz, Valéria de Oliveira

    Microbial biotransformations constitute an important alternative as models for drug metabolism study in mammalians and have been used for the industrial synthesis of chemicals with pharmaceutical purposes. Several microorganisms with unique biotransformation ability have been found by intensive screening and put in commercial applications. Ten isolates of Beauveria sp genus filamentous fungi, isolated from soil in the central Brazil, and Beauveria bassiana ATCC 7159 were evaluated for their capability of quercetin biotransformation. Biotransformation processes were carried out for 24 up to 96 hours and monitored by mass spectrometry analyses of the culture broth. All strains were able to metabolize quercetin, forming mammalian metabolites. The results were different from those presented by other microorganisms previously utilized, attrackting attention because of the great diversity of reactions. Methylated, sulphated, monoglucuronidated, and glucuronidated conjugated metabolites were simultaneously detected. Biotransformações microbianas constituem uma alternativa importante como modelo para o estudo do metabolismo de medicamentos em mamíferos e são empregadas em processos sintéticos industriais com propósitos farmacêuticos. Diversos microrganismos com potencial para biotransformação têm sido encontrados através de screening intensivo e aplicados comercialmente. Dez cepas de fungos filamentosos do gênero Beauveria, isolados na região central do Brasil, e a cepa Beauveria bassiana ATCC 7159 foram avaliadas quanto à capacidade de biotransformação da quercetina. As reações de biotransformações foram realizadas por um período de 24 a 96 horas, e monitoradas através de espectrometria de massas do meio reacional. Todas as cepas foram capazes de metabolizar a quercetina, formando metabólitos encontrados nos mamíferos. Os resultados foram diferentes dos resultados apresentados por outros microrganismos utilizados anteriormente e chamam a atenção devido à diversidade das reações evidenciadas. Diferentes metabólitos conjugados foram detectados simultaneamente: metilados, sulfatados, monoglicuronados, e glicuronados


  • Open Access

    CITOCROMOS P450 E BIOTRANSFORMAÇÃO MICROBIANA

    by Eula Maria de Melo Barcelos Costa, Valéria De Oliveira, Fabiana Cristina Pimenta

    Resumo O interesse científico sobre o sistema enzimático citocromo P450 tem aumentado consideravelmente. Sua participação no metabolismo oxidativo de xenobióticos propicia a conversão de compostos lipofihicos em hidrofíhicos, facilitando a excreção celular. A similaridade desse sistema em mamíferos e em diversos microrganismos permite empregar a biotransformação microbiana para obter quantidades consideráveis de metabólitos de difícil obtenção por meio de modelos animais ou por síntese química. Os metabólitos obtidos são identificados e caracterizados quanto às suas estruturas químicas, propriedades e atividades biológicas. Diversos fármacos ativos em doenças tropicais tem sido pesquisados por intermédio dessa metodologia.